drug development

Combining the Powers of Single Cell Sequencing and AI in Understanding Disease Biology and Drug Development
Combining the Powers of Single Cell Sequencing and AI in Understanding Disease Biology and Drug Development
Xtalks
artificial intelligence
single cell sequencing
drug development
Flag link:
It’s official: “pipeline in a product” is a thing
It’s official: “pipeline in a product” is a thing
EP Vantage
drug development
Big Pharma
pipeline in a product
Flag link:
Here’s how Covid-19 has affected funding, development in infectious diseases
Here’s how Covid-19 has affected funding, development in infectious diseases
MedCity News
COVID-19
pandemic
infectious diseases
drug development
Flag link:
10 most valuable R&D projects in the pharmaceutical industry pipeline
10 most valuable R&D projects in the pharmaceutical industry pipeline
Beckers Hospital Review
R&D
drug development
Eli Lilly
Novartis
Argenx
Bristol-Myers Squibb
Vir Biotechnolgy
Biogen
GSK
Iovance
Roche
Flag link:
Deep Dive Into Big Pharma AI Productivity: One Study Shaking The Pharmaceutical Industry
Deep Dive Into Big Pharma AI Productivity: One Study Shaking The Pharmaceutical Industry
Forbes
artificial intelligence
machine learning
pharma industry
drug development
AstraZeneca
Novartis
Flag link:
'Longevity as a service': Insilico spins off AI biotech that trains deep learning on anti-aging treatments
'Longevity as a service': Insilico spins off AI biotech that trains deep learning on anti-aging treatments
Endpoints
Insilico
anti-aging
artificial intelligence
drug development
Flag link:
Alzheimer’s Drugs on Verge of Becoming Mainstream Medicine, but Early Intervention Still is Needed
Alzheimer’s Drugs on Verge of Becoming Mainstream Medicine, but Early Intervention Still is Needed
BioSpace
Alzheimer's disease
drug development
diagnostics
aducanumab
Biogen
Flag link:
Merck teams up with cancer startup Foghorn in $425M deal
Merck teams up with cancer startup Foghorn in $425M deal
Fierce Biotech
Merck
Foghorn Therapeutics
cancer
drug development
Flag link:
Data show panic and disorganization dominate the study of Covid-19 drugs
Data show panic and disorganization dominate the study of Covid-19 drugs
Stat
drug development
clinical trials
pandemic
COVID-19
Flag link:
Coalition of drugmakers to unveil $1B venture to pursue antibiotics
Coalition of drugmakers to unveil $1B venture to pursue antibiotics
Beckers Hospital Review
Big Pharma
drug development
antibiotics
innovation
Eli Lilly
Pfizer
Merck
Boehringer Ingelheim
Bayer
CARB-X
Flag link:
Big pharma sports smallest late-stage pipeline for a decade
Big pharma sports smallest late-stage pipeline for a decade
EP Vantage
Big Pharma
drug development
pandemic
COVID-19
Flag link:
'Warp Speed' plan for coronavirus vaccines comes into focus
'Warp Speed' plan for coronavirus vaccines comes into focus
BioPharma Dive
Operation Warp Speed
Donald Trump
pandemic
COVID-19
drug development
vaccines
Flag link:
Cows Help With COVID-19 Treatment, No Bull
Cows Help With COVID-19 Treatment, No Bull
NPR
SAB Biotherapeutics
pandemic
COVID-19
drug development
polyclonal antibodies
Flag link:
Large R&D Investments By Big Pharma Crucial In Fighting Covid-19, But Can It Last?
Large R&D Investments By Big Pharma Crucial In Fighting Covid-19, But Can It Last?
Forbes
R&D
COVID-19
pandemic
drug discovery
drug development
Flag link:
Takeda-partnered Shattuck nabs mighty $118M funding round for immunotherapy, autoimmune work
Takeda-partnered Shattuck nabs mighty $118M funding round for immunotherapy, autoimmune work
Fierce Biotech
Takeda
Shattuck
funding
drug development
Flag link:
Orphan drug incentives reviewed at BIO
Orphan drug incentives reviewed at BIO
RAPS.org
BIO 2020
orphan drugs
drug development
Flag link:
Gilead's next step on coronavirus: inhaled remdesivir, other easier-to-use versions
Gilead's next step on coronavirus: inhaled remdesivir, other easier-to-use versions
Reuters
Gilead Sciences
drug development
remdesivir
COVID-19
Flag link:
Regeneron to expand development deal with Intellia Therapeutics
Regeneron to expand development deal with Intellia Therapeutics
Marketwatch
Regeneron
Intellia Therapeutics
hemophilia A
hemophilia B
CRISPR
drug development
Flag link:
The WHO launched a voluntary Covid-19 product pool. What happens next?
The WHO launched a voluntary Covid-19 product pool. What happens next?
Stat
WHO
COVID-19
patents
drug development
pandemic
Flag link:
U.S. is ahead of China in vaccine race, former FDA chief says
U.S. is ahead of China in vaccine race, former FDA chief says
Politico
China
vaccines
COVID-19
drug development
Scott Gottlieb
Flag link:

Pages